← Eichor
Study identifier: NCT05810571 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Comparison of Postoperative Analgesic Efficacy of the Erector Spina Plane Block and Quadratus Lumborum Block in Open Nephrectomy: a Prospective Randomized Clinical Study

Condition: Renal Cell Carcinoma  ·  Sponsor: Kocaeli University

PhaseNA
Planned participants60
Who can joinAll sexes, 18 Years to 85 Years
Healthy volunteersNo

About this study

patients who will undergo elective open nephrectomy will be divided into three groups; the control (PCA), the erector spina plane block, and the quadratus lumborum block. After standard anesthesia induction and monitorization then Bispectral index monitoring will be applied to all patients. Anesthesia will be maintained using sevoflurane in a mixture of oxygen and air. Continuous remifentanil infusion will be used for analgesia. Then patient's numeric rating scales and morphine pca consumptions will be recorded for one day.

This description comes directly from the study's public registry record.

Talk to the study team

zehra ipek Arslan AYDIN, Professor  ·  00905325011339  ·  zehraipek48@gmail.com

Zehra ipek Arslan, Professor  ·  00905325011339  ·  zehraipek48@gmail.com

Always discuss trial participation with your own doctor first.

Locations (2)

Kocaeli University Medical Facultyİzmit, Turkey (Türkiye)Recruiting
Kocaeli University Medical FacultyKocaeli, Turkey (Türkiye)Active Not Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05810571